Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2003

Content (17 Articles)

Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study

Emilio Esteban, Antonio Modollel, Luis González de Sande, Isabel Palacio, Isabel Muñiz, Yolanda Fernández, Norberto Corral, Joaquin Fra, Marian Sala, Jose María Vieitez, Enrique Estrada, AJ Lacave

Duration of Hormone Replacement Therapy, Breast Tumour Size and Grade in a Screening Programme

Dorota M Gertig, Bircan Erbas, Ashley Fletcher, Alison Amos, Anne M Kavanagh

Restoration of Tumor-Specific HLA Class I Restricted Cytotoxicity in Tumor Infiltrating Lymphocytes of Advanced Breast Cancer Patients by in vitro Stimulation with Tumor Antigen-Pulsed Autologous Dendritic Cells

Rena Kass, Stefania Bellone, Michela Palmieri, Stefania Canè, Eliana Bignotti, Rhonda Henry-Tillman, Laura Hutchins, Martin J. Cannon, Suzanne Klimberg, Alessandro D. Santin

Involvement of TGF-βs/TβRs System in Tumor Progression of Murine Mammary Adenocarcinomas

M. Cecilia Daroqui, Lydia I. Puricelli, Alejandro J. Urtreger, Elisa Bal de Kier Joffé, Patricia V. Elizalde, Guillermo M. Lanuza

Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors

K.W. Colston, G. Pirianov, E. Bramm, K.J. Hamberg, L. Binderup

Novel Drug Amooranin Induces Apoptosis Through Caspase Activity in Human Breast Carcinoma Cell Lines

Thangaiyan Rabi, Cheppail Ramachandran, Hugo B. Fonseca, Raveendran P.K. Nair, Arturo Alamo, Steven J. Melnick, Enrique Escalon

Clinical Significance of AIB1 Expression in Human Breast Cancer

H. Iwase, Y. Omoto, T. Toyama, H. Yamashita, Y. Hara, H. Sugiura, Z. Zhang

CTCF Gene Mutations in Invasive Ductal Breast Cancer

Sebastian Aulmann, Hendrik Bläker, Roland Penzel, Ralf Joachim Rieker, Herwart F. Otto, Hans Peter Sinn

Oncogene HER-2 in Canine Mammary Gland Carcinomas

J. Martín de las Mulas, J. Ordás, Y. Millán, V. Fernández-Soria, S. Ramón y Cajal

Authors Index

Author Index, Volume 80

Subject Index

Subject Index, Volume 80

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine